Abstract:OBJECTIVE:To study the effect and mechanism of berberine (BER) on the proliferation and differentiation of adipocytes.METHODS:The proliferation of 3T3-L1 pre-adipocytes was detected by XTT method. Lipid droplets accumulated in the cytoplasm of adipocytes in the differentiating process were observed by oil red O staining and quantified by colorimetry. The expressions of peroxisome proliferation activated receptor gamma (PPARgamma), CAAT/enhancer binding protein alpha (C/EBPalpha) mRNA and protein were detected by Real-time PCR and Western blotting respectively.RESULTS:Intervention with BER in concentration below 10 micromol/L for 24 h showed insignificant effect on the proliferation of adipocytes, as compared with that in the control group (P > 0.05); but that in concentrations 20, 40 and 80 micromol/L revealed significant suppressive effect; that in different concentrations acting for 48 h and 72 h could affect the proliferation and the effect displayed a dose-dependent manner, i. e. the higher the concentration of BER, the more apparent the suppression, showing significant difference as compared with those in the control group (P <0.05 or P <0.01). The pre-adipocyte treated with 10 micromol/L BER showed that the lipid droplets in the cytoplasm significantly lessened, so did the expression of differentiation related factor PPAR gamma mRNA as well as the expressions of C/EBPalpha mRNA and protein, as compared with those in the blank control group and the group intervened with rosiglitazone, the difference was significant (P < 0.05 or P < 0.01).CONCLUSIONS:BER can suppress the proliferation and differentiation of 3T3-L1 pre-adipocytes, reduce the accumulation of lipid drops in the adipocyte differentiating process, which may be associated with its effects in decreasing the expressions of adipocyte differentiation related gene PPARgamma, C/EBPalpha mRNA and protein. The study provides a basis for applying BER on the prevention and treatment of such metabolic related diseases as obesity.

Suppressive Effects of Barley Β‐glucans with Different Molecular Weight on 3T3‐L1 Adipocyte Differentiation

Anti-α-Glucosidase Activities and Bioactive Components of Tibetan Hull-Less Barley Bran Extracts

Low Molecular Weight Barley β-Glucan Affects Glucose and Lipid Metabolism by Prebiotic Effects

Metabolomics Reveal the Regulatory Effect of Polysaccharides from Fermented Barley Bran Extract on Lipid Accumulation in HepG2 Cells

Fermented Barley Β‐glucan Regulates Fat Deposition in Caenorhabditis Elegans

Metabolomics Reveals the Effects of Lactiplantibacillus Plantarum Dy-1 Fermentation on the Lipid-Lowering Capacity of Barley Β-Glucans in an in Vitro Model of Gut-Liver Axis.

Metabolomics reveals the effects of<i> Lactiplantibacillus</i><i> plantarum</i> dy-1 fermentation on the lipid-lowering capacity of barley 13-glucans in an<i> in</i><i> vitro</i> model of gut-liver axis

Lactobacillus Plantarum Dy-1 Fermented Barley Extraction Activates White Adipocyte Browning in High-Fat Diet-Induced Obese Rats.

[Effect of berberine on the differentiation of adipocyte].

[Effects of Berberine on Cell Proliferation, Peroxisome Proliferation Activated Receptor Gamma, CAAT/enhancer Binding Protein Mrna and Protein Expression in 3T3-L1 Pre-Adipocytes].

Barley β-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation in high fat diet fed mice

Barley b-glucan improves metabolic condition via short-chain fatty acids produced by gut microbial fermentation

Inhibitory Effect of Fermented Selected Barley Extracts with Lactobacillus Plantarum Dy-1 on the Proliferation of Human HT-29 Cells

Physiological effects of concentrated barley beta-glucan in mildly hypercholesterolemic adults

Barley β-glucan inhibits digestion of soybean oil in vitro and lipid-lowering effects of digested products in cell co-culture model

Dietary Supplementation with Lactobacillus Plantarum Dy-1 Fermented Barley Suppresses Body Weight Gain in High-Fat Diet-Induced Obese Rats.

Effect of Solid-State Fermented Brown Rice Extracts on 3T3-L1 Adipocyte Differentiation

Barley consumption under a high-fat diet suppresses lipogenic genes through altered intestinal bile acid composition

Hulless barley polyphenol extract inhibits adipogenesis in 3T3-L1 cells and obesity related-enzymes

Over‐expression of (1,3;1,4)‐β‐d‐glucanase Isoenzyme EII Gene Results in Decreased (1,3;1,4)‐β‐d‐glucan Content and Increased Starch Level in Barley Grains

Antiobesity Effect of Lactiplantibacillus Plantarum Fermented Barley Extracts Via the Interactions with Gut Microbiota of the Obese Adult Humans